Bentham Science Logo

Track Your Manuscript:


CNS & Neurological Disorders - Drug Targets

Formerly: Current Drug Targets - CNS & Neurological Disorders

Volume 21, 10 Issues, 2022
ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)
This journal supports open access

Contents

CNS & Neurological Disorders - Drug Targets , Volume 9 - Number 6




Organelle Stress Sensors and Cell Death Mechanisms in Neurodegenerative Diseases

, 9(6): 679 - 692

Ricardo J.S. Viana, Maria B. Fonseca, Rita M. Ramalho, Ana F. Nunes and Cecilia M.P. Rodrigues


DOI: 10.2174/187152710793237511




Wnt Signalling is a Relevant Pathway Contributing to Amyloid Beta-Peptide-Mediated Neuropathology in Alzheimers Disease

, 9(6): 720 - 726

Odete A.B. da Cruz e Silva, Ana Gabriela Henriques, Sara Catarina Timoteo Santos Domingues and Edgar F. da Cruz e Silva


DOI: 10.2174/187152710793237458









Are Anti-Angiogenic Drugs Useful in Neurodegenerative Disorders?

, 9(6): 807 - 812

Daniele De Filippis, Mariateresa Cipriano, Giuseppe Esposito, Caterina Scuderi, Luca Steardo and Teresa Iuvone


DOI: 10.2174/187152710793237485



Editor-in-Chief

Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria
Messina
(Italy)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets - CNS & Neurological Disorders was launched in 2002 and later renamed in 2006 as CNS & Neurological Disorders - Drug Targets.

Advertisement

Jan-2022-banMechanisms-of-Metabolic-Disorders-(MMD)

Related Journals

Related eBooks

eBooks Catalog